Pancreatic Cancer Research

ResearcherErasmus MCActive in the last 2 years

Peter Derk Siersema

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6940-8499; OpenAlex author ID A5074268246. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2012: 2 papers · 2013: 3 papers · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 10

  1. Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in patients with pancreatic adenocarcinoma. Last author DOI 10.1016/j.pan.2025.01.011↗
  2. Pancreatic Cancer Awareness Issue 2019. Co-author DOI 10.1055/a-1019-5433↗
  3. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Co-author DOI 10.1002/ijc.31146↗
  4. Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutritio… Co-author DOI 10.1002/ijc.29175↗
  5. Technical advances in endoscopic ultrasound-guided fiducial placement for the treatment of pancreatic cancer. Co-author DOI 10.1055/s-0034-1392274↗
  6. Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1002/ijc.27637↗
  7. Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and… Co-author DOI 10.1002/ijc.27875↗
  8. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Co-author DOI 10.1136/gutjnl-2012-303006↗
  9. Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.27547↗
  10. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Co-author DOI 10.1038/bjc.2012.172↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John J. Hermans · 1 shared paper, 2025 · strength 0.25
  2. Geke Litjens · 1 shared paper, 2025 · strength 0.25
  3. Fons van der Sommen · 1 shared paper, 2025 · strength 0.25
  4. T. H. Perik · 1 shared paper, 2025 · strength 0.25
  5. Mike J.P. de Jong · 1 shared paper, 2025 · strength 0.25
  6. Eric J. Duell · 6 shared papers, 2012–2015 · strength 0.13
  7. Malin Sund · 6 shared papers, 2012–2015 · strength 0.13
  8. H. Bas Bueno-de-Mesquita · 5 shared papers, 2012–2015 · strength 0.12
  9. Elio Ríboli · 5 shared papers, 2012–2015 · strength 0.11
  10. Esther Molina‐Montes · 5 shared papers, 2012–2015 · strength 0.11
  11. Verena A. Grote · 5 shared papers, 2012–2015 · strength 0.11
  12. Paolo Vineis · 5 shared papers, 2012–2015 · strength 0.11
  13. Weimin Ye · 5 shared papers, 2012–2013 · strength 0.10
  14. Dominique S. Michaud · 4 shared papers, 2012–2013 · strength 0.08
  15. Disaya Chavalitdhamrong · 1 shared paper, 2015 · strength 0.07
  16. Mihir S. Wagh · 1 shared paper, 2015 · strength 0.07
  17. Rudolf Kaaks · 3 shared papers, 2012–2015 · strength 0.07
  18. Guri Skeie · 3 shared papers, 2012–2015 · strength 0.07
  19. Suzanne M. Jeurnink · 2 shared papers, 2013–2015 · strength 0.05
  20. Leila Luján‐Barroso · 2 shared papers, 2012–2013 · strength 0.04
  21. Sabine Rohrmann · 2 shared papers, 2012–2013 · strength 0.04
  22. Teresa Norat · 2 shared papers, 2012–2013 · strength 0.04
  23. Max B. Leenders · 1 shared paper, 2015 · strength 0.03
  24. Fränzel J.B. van Duijnhoven · 1 shared paper, 2015 · strength 0.03
  25. Jacques Izard · 1 shared paper, 2013 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.